Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial
Sign Up to like & getrecommendations! Published in 2017 at "Age and Ageing"
DOI: 10.1093/ageing/afx045
Abstract: Background inhibition of acetylcholinesterase (AChE) has been a effective treatment for Alzheimer's disease (AD). Octohydroaminoacridine, a new AChE inhibitor, is a potential treatment for AD. Method we conducted a multicenter, randomised, double blind, placebo-controlled, parallel-group… read more here.
Keywords: alzheimer disease; high dose; dose group; group ... See more keywords
Acupuncture for chronic sciatica: protocol for a multicenter randomised controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-054566
Abstract: Background Chronic Sciatica is a disabling condition causing considerable medical, social and financial implications. Currently, there is no recognised long-term effective treatment to alleviate sciatica. Acupuncture has been widely used for treating chronic pains with… read more here.
Keywords: acupuncture chronic; chronic sciatica; multicenter randomised; sciatica ... See more keywords